Grifols reported EUR2.16B in Current Liabilities for its fiscal quarter ending in December of 2024.


Current Liabilities Change Date
Alaunos Therapeutics USD 4K 822K Oct/2024
GlaxoSmithKline GBP 20.38B 453M Jun/2025
Grifols EUR 2.16B 199.43M Dec/2024
Life Technologies USD 15.53M 563K Jun/2025